Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Behavioral Symptoms in Severe Alzheimer's
NCT00711204Phase 4Withdrawn
- Sponsor
- Eisai Co., Ltd.
- Start
- Jan 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of donepezil in Alzheimer's disease (AD), sponsored by Eisai Co., Ltd.. Planned start Jan 2008; status: withdrawn.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00711204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00711204.